ICON Surpasses ESG Targets Early, Boosts AI and Patient Access
Event summary
- ICON achieved an EcoVadis score of 87/100, placing it in the top 1% of assessed organizations.
- The company reduced Scope 1 and 2 greenhouse gas emissions by 73.56% compared to the 2019 baseline, exceeding its near-term SBTi target.
- ICON's Orbis platform won the AI Project of the Year award at the Analytics & AI Awards 2025.
- The company supported over 1,370 clinical studies involving more than 411,400 patients in 2025.
- ICON's corporate giving program has funded over 135 charities since its launch.
The big picture
ICON's 2025 ICON Cares Report underscores its commitment to sustainability, innovation, and patient impact, aligning with broader industry trends toward ESG integration and AI-driven operational excellence. The company's early achievement of its 2030 energy reduction target and recognition by TIME and Forbes highlight its leadership in corporate governance and healthcare equity. With over 40,200 employees across 55 countries, ICON's scale positions it to influence global clinical research standards.
What we're watching
- Sustainability Leadership
- Whether ICON can maintain its top 1% EcoVadis ranking amid increasing regulatory scrutiny on ESG claims.
- AI Integration
- The pace at which ICON deploys AI capabilities across clinical trial operations and its impact on operational efficiency.
- Patient Access Expansion
- How ICON's partnerships will enhance the representativeness and accessibility of clinical research globally.
Related topics